BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26663021)

  • 1. Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.
    Unalp-Arida A; Ruhl CE
    Hepatology; 2016 Apr; 63(4):1170-83. PubMed ID: 26663021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.
    Ruhl CE; Everhart JE
    Gastroenterology; 2009 Feb; 136(2):477-85.e11. PubMed ID: 19100265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of serum liver enzyme levels and their changes over time with all-cause and cause-specific mortality in the general population: a large-scale national health screening cohort study.
    Kim KN; Joo J; Sung HK; Kim CH; Kim H; Kwon YJ
    BMJ Open; 2019 Jun; 9(5):e026965. PubMed ID: 31154308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated liver enzymes and cardiovascular mortality: a systematic review and dose-response meta-analysis of more than one million participants.
    Rahmani J; Miri A; Namjoo I; Zamaninour N; Maljaei MB; Zhou K; Cerneviciute R; Mousavi SM; Varkaneh HK; Salehisahlabadi A; Zhang Y
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):555-562. PubMed ID: 30614883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-glutamyl transpeptidase elevation is associated with metabolic syndrome, hepatic steatosis, and fibrosis in patients with nonalcoholic fatty liver disease: A community-based cross-sectional study.
    Chen LW; Huang MS; Shyu YC; Chien RN
    Kaohsiung J Med Sci; 2021 Sep; 37(9):819-827. PubMed ID: 34002481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association between Liver Enzymes and Mortality Stratified by Non-Alcoholic Fatty Liver Disease: An Analysis of NHANES III.
    Grob SR; Suter F; Katzke V; Rohrmann S
    Nutrients; 2023 Jul; 15(13):. PubMed ID: 37447388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016.
    Denova-Gutiérrez E; Lara-Castor L; Hernández-Alcaraz C; Hernández-Ávila M; Aguilar-Salinas C; Kershenobich D; Barquera S
    Ann Hepatol; 2021 Dec; 26():100562. PubMed ID: 34653686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease.
    Lazo M; Rubin J; Clark JM; Coresh J; Schneider AL; Ndumele C; Hoogeveen RC; Ballantyne CM; Selvin E
    J Hepatol; 2015 Apr; 62(4):841-7. PubMed ID: 25433159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of liver enzymes with incident diabetes in US Hispanic/Latino adults.
    Hua S; Qi Q; Kizer JR; Williams-Nguyen J; Strickler HD; Thyagarajan B; Daviglus M; Talavera GA; Schneiderman N; Cotler SJ; Cai J; Kaplan R; Isasi CR
    Diabet Med; 2021 Aug; 38(8):e14522. PubMed ID: 33434318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated alanine aminotransferase and low aspartate aminotransferase/alanine aminotransferase ratio are associated with chronic kidney disease among middle-aged women: a cross-sectional study.
    Ochiai H; Shirasawa T; Yoshimoto T; Nagahama S; Watanabe A; Sakamoto K; Kokaze A
    BMC Nephrol; 2020 Nov; 21(1):471. PubMed ID: 33172399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship Between Liver Enzymes and Insulin Resistance in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease.
    Sheng X; Che H; Ji Q; Yang F; Lv J; Wang Y; Xian H; Wang L
    Horm Metab Res; 2018 May; 50(5):397-402. PubMed ID: 29723898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver fibrosis scores predict liver disease mortality in the United States population.
    Unalp-Arida A; Ruhl CE
    Hepatology; 2017 Jul; 66(1):84-95. PubMed ID: 28195363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma.
    Huang H; Wang XP; Li XH; Chen H; Zheng X; Lin JH; Kang T; Zhang L; Chen PS
    BMC Cancer; 2017 Aug; 17(1):544. PubMed ID: 28806937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study.
    Zou Y; Zhong L; Hu C; Sheng G
    Lipids Health Dis; 2020 Nov; 19(1):245. PubMed ID: 33239040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating liver enzymes and risks of chronic diseases and mortality in the prospective EPIC-Heidelberg case-cohort study.
    Katzke V; Johnson T; Sookthai D; Hüsing A; Kühn T; Kaaks R
    BMJ Open; 2020 Mar; 10(3):e033532. PubMed ID: 32152162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.
    Kim D; Kim WR; Kim HJ; Therneau TM
    Hepatology; 2013 Apr; 57(4):1357-65. PubMed ID: 23175136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between serum liver enzymes and all-cause mortality: The Japan Public Health Center-based Prospective Study.
    Yuwaki K; Shimazu T; Yamagiwa Y; Inoue M; Goto A; Yamaji T; Iwasaki M; Sawada N; Tsugane S;
    Liver Int; 2019 Aug; 39(8):1566-1576. PubMed ID: 30566759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality.
    Arndt V; Brenner H; Rothenbacher D; Zschenderlein B; Fraisse E; Fliedner TM
    Int Arch Occup Environ Health; 1998 Sep; 71(6):405-12. PubMed ID: 9766914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis--a comparison with routine biochemical markers.
    Chan WK; Sthaneshwar P; Nik Mustapha NR; Mahadeva S
    PLoS One; 2014; 9(9):e105903. PubMed ID: 25184298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.